The global probiotic ingredients market size accounted for USD 7.00 billion in 2024, grew to USD 7.86 billion in 2025 and is predicted to surpass around USD 22.14 billion by 2034, representing a healthy CAGR of 12.20% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Probiotic Ingredients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Probiotic Ingredients Market, by Type, 2024-2034
8.1.1. Bifidobacterium animalis
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Bifidobacterium breve
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Bifidobacterium longum
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Lactobacillus Reuteri
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Probiotic Ingredients Market, by Application, 2024-2034
9.1.1. Food and Beverages
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Animal Feed
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Probiotic Ingredients Market, by Components, 2024-2034
10.1.1. Bacterica
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Yeast
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Probiotic Ingredients Market, by Form, 2024-2034
11.1.1. Dry Form
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Liquid Form
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Probiotic Ingredients Market, by End User, 2024-2034
12.1.1. Human Probiotic
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Animal Probiotic
12.1.2.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.3. Market Revenue and Forecast, by Components (2021-2034)
13.1.4. Market Revenue and Forecast, by Form (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Components (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Form (2021-2034)
13.1.7. Market Revenue and Forecast, by End User (2021-2034)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.1.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.8.3. Market Revenue and Forecast, by Components (2021-2034)
13.1.8.4. Market Revenue and Forecast, by Form (2021-2034)
13.1.8.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.3. Market Revenue and Forecast, by Components (2021-2034)
13.2.4. Market Revenue and Forecast, by Form (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Components (2021-2034)
13.2.7. Market Revenue and Forecast, by Form (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Components (2021-2034)
13.2.10. Market Revenue and Forecast, by Form (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Components (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Form (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Components (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Form (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.3. Market Revenue and Forecast, by Components (2021-2034)
13.3.4. Market Revenue and Forecast, by Form (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Components (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Form (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Components (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Form (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Components (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Form (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Components (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Form (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.3. Market Revenue and Forecast, by Components (2021-2034)
13.4.4. Market Revenue and Forecast, by Form (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Components (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Form (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Components (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Form (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Components (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Form (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Components (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Form (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.3. Market Revenue and Forecast, by Components (2021-2034)
13.5.4. Market Revenue and Forecast, by Form (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Components (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Form (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Components (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Form (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. ProbioFerm
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Glac Biotech
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DSM
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Vitakem Nutraceutical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio Gaia
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Probium
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kerry Group
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample